Chromatographic Method Development and Validation for Simultaneous Determination of Apixaban and Rivaroxaban Using RGB Detection and Green Chemistry Approach
International Journal of Drug Delivery Technology · 09.06.2026 · 16 (47s)
DOI: 10.25258/ijddt.16.47s.136 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 09.06.2026. Verfasst von Deepika Dhomse und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Apixaban and Rivaroxaban are direct oral anticoagulants (DOACs) that belong to the class of Factor Xa inhibitors. These drugs are widely prescribed for the prevention and treatment of venous thromboembolism, non-valvular atrial fibrillation, and pulmonary embolism. Owing to their narrow therapeutic index and the growing prevalence of polypharmacy in elderly patients, the development of a precise, sensitive, and selective analytical method for their simultaneous quantification is of considerable clinical and regulatory importance.
Objective
The present study aims to develop and validate a novel reversed-phase high-performance liquid chromatographic (RP-HPLC) method for the simultaneous determination of Apixaban and Rivaroxaban in bulk drug and pharmaceutical formulations using RGB colorimetric detection as an eco-friendly and cost-effective alternative to conventional UV detection.
Methods
Chromatographic separation was achieved on a C18 column (250 mm x 4.6 mm, 5 μm) using an optimized mobile phase consisting of acetonitrile and 10 mM ammonium acetate buffer (pH 4.5) in a 60:40 v/v ratio at a flow rate of 1.0 mL/min. RGB detection was implemented using a digital image acquisition system with analysis performed through the ImageJ software platform. Method validation was carried out strictly in accordance with International Council for Harmonisation (ICH) Q2(R1) guidelines, encompassing parameters of specificity, linearity,
Zitieren
APA
Dhomse, D., Kalita, R., Chothave, M., Jagtap, V., Chaudhar, P., & Nath, J. (2026). Chromatographic Method Development and Validation for Simultaneous Determination of Apixaban and Rivaroxaban Using RGB Detection and Green Chemistry Approach. International Journal of Drug Delivery Technology, 16(47s). https://doi.org/10.25258/ijddt.16.47s.136
Vancouver
Dhomse D, Kalita R, Chothave M, Jagtap V, Chaudhar P, Nath J. Chromatographic Method Development and Validation for Simultaneous Determination of Apixaban and Rivaroxaban Using RGB Detection and Green Chemistry Approach. International Journal of Drug Delivery Technology. 2026;16(47s). doi:10.25258/ijddt.16.47s.136
BibTeX
@article{Dhomse2026,
author = {Dhomse, Deepika and Kalita, Ratul and Chothave, Madhura and Jagtap, Vrushali and Chaudhar, Priyanka and Nath, Jubin},
title = {Chromatographic Method Development and Validation for Simultaneous Determination of Apixaban and Rivaroxaban Using RGB Detection and Green Chemistry Approach},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {47s},
doi = {10.25258/ijddt.16.47s.136}
}
EUVIMED